2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Snai1
|
ENSMUSG00000042821.7 | snail family zinc finger 1 |
Zeb1
|
ENSMUSG00000024238.7 | zinc finger E-box binding homeobox 1 |
Snai2
|
ENSMUSG00000022676.6 | snail family zinc finger 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zeb1 | mm10_v2_chr18_+_5591860_5591902 | -0.85 | 4.5e-04 | Click! |
Snai1 | mm10_v2_chr2_+_167538192_167538210 | -0.71 | 1.0e-02 | Click! |
Snai2 | mm10_v2_chr16_+_14705832_14705858 | -0.66 | 1.9e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_69965396 | 31.14 |
ENSMUST00000018713.6
|
Cldn7
|
claudin 7 |
chr11_+_68556186 | 13.73 |
ENSMUST00000053211.6
|
Mfsd6l
|
major facilitator superfamily domain containing 6-like |
chr11_+_69964758 | 13.08 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr13_-_57907587 | 12.27 |
ENSMUST00000172326.1
|
Spock1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 |
chr12_-_73546383 | 12.03 |
ENSMUST00000042975.5
|
Tmem30b
|
transmembrane protein 30B |
chr8_-_113848615 | 10.15 |
ENSMUST00000093113.4
|
Adamts18
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18 |
chr7_-_143074037 | 10.05 |
ENSMUST00000136602.1
|
Trpm5
|
transient receptor potential cation channel, subfamily M, member 5 |
chr18_+_74442551 | 9.09 |
ENSMUST00000121875.1
|
Myo5b
|
myosin VB |
chr1_-_134234492 | 8.81 |
ENSMUST00000169927.1
|
Adora1
|
adenosine A1 receptor |
chr2_+_180725263 | 8.32 |
ENSMUST00000094218.3
|
Slc17a9
|
solute carrier family 17, member 9 |
chr4_+_118527229 | 8.08 |
ENSMUST00000030261.5
|
2610528J11Rik
|
RIKEN cDNA 2610528J11 gene |
chr17_+_23660477 | 8.02 |
ENSMUST00000062967.8
|
Ccdc64b
|
coiled-coil domain containing 64B |
chr6_-_48445373 | 7.68 |
ENSMUST00000114563.1
ENSMUST00000114558.1 ENSMUST00000101443.3 ENSMUST00000114564.1 |
Zfp467
|
zinc finger protein 467 |
chr5_+_125003440 | 7.18 |
ENSMUST00000036109.3
|
Fam101a
|
family with sequence similarity 101, member A |
chr5_+_35056813 | 6.70 |
ENSMUST00000101298.2
ENSMUST00000114270.1 ENSMUST00000133381.1 |
Dok7
|
docking protein 7 |
chr5_+_35057059 | 6.60 |
ENSMUST00000050709.3
|
Dok7
|
docking protein 7 |
chr17_+_57062231 | 6.53 |
ENSMUST00000097299.3
ENSMUST00000169543.1 ENSMUST00000163763.1 |
Crb3
|
crumbs homolog 3 (Drosophila) |
chr11_+_120530688 | 6.39 |
ENSMUST00000026119.7
|
Gcgr
|
glucagon receptor |
chr13_+_24845122 | 6.36 |
ENSMUST00000006893.8
|
D130043K22Rik
|
RIKEN cDNA D130043K22 gene |
chr18_+_74442500 | 6.35 |
ENSMUST00000074157.6
|
Myo5b
|
myosin VB |
chr17_+_24752980 | 6.10 |
ENSMUST00000044922.6
|
Hs3st6
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 6 |
chr5_-_93045022 | 5.88 |
ENSMUST00000061328.5
|
Sowahb
|
sosondowah ankyrin repeat domain family member B |
chr6_+_90619241 | 5.86 |
ENSMUST00000032177.8
|
Slc41a3
|
solute carrier family 41, member 3 |
chr7_+_141079759 | 5.83 |
ENSMUST00000066873.4
ENSMUST00000163041.1 |
Pkp3
|
plakophilin 3 |
chr17_+_57062486 | 5.71 |
ENSMUST00000163628.1
|
Crb3
|
crumbs homolog 3 (Drosophila) |
chr10_-_75797528 | 5.69 |
ENSMUST00000120177.1
|
Gstt1
|
glutathione S-transferase, theta 1 |
chr7_-_141100526 | 5.60 |
ENSMUST00000097958.2
|
Sigirr
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr11_-_120648104 | 5.45 |
ENSMUST00000026134.2
|
Myadml2
|
myeloid-associated differentiation marker-like 2 |
chr9_-_121792478 | 5.34 |
ENSMUST00000035110.4
|
Hhatl
|
hedgehog acyltransferase-like |
chr7_-_100658394 | 5.32 |
ENSMUST00000138830.1
ENSMUST00000107044.3 ENSMUST00000116287.2 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr7_+_4119556 | 5.26 |
ENSMUST00000079415.5
|
Ttyh1
|
tweety homolog 1 (Drosophila) |
chr11_+_113619318 | 5.26 |
ENSMUST00000146390.2
ENSMUST00000106630.1 |
Sstr2
|
somatostatin receptor 2 |
chr7_-_19796789 | 5.05 |
ENSMUST00000108449.2
ENSMUST00000043822.7 |
Cblc
|
Casitas B-lineage lymphoma c |
chr17_-_25256274 | 4.99 |
ENSMUST00000182435.1
ENSMUST00000169109.2 ENSMUST00000182056.1 |
Baiap3
|
BAI1-associated protein 3 |
chr16_+_36693972 | 4.96 |
ENSMUST00000023617.6
ENSMUST00000089618.3 |
Ildr1
|
immunoglobulin-like domain containing receptor 1 |
chr1_-_171437288 | 4.94 |
ENSMUST00000181499.1
|
Gm26641
|
predicted gene, 26641 |
chr16_+_36694024 | 4.94 |
ENSMUST00000119464.1
|
Ildr1
|
immunoglobulin-like domain containing receptor 1 |
chr3_+_146117451 | 4.79 |
ENSMUST00000140214.1
|
Mcoln3
|
mucolipin 3 |
chr12_+_30911659 | 4.78 |
ENSMUST00000020997.8
ENSMUST00000110880.2 |
Sh3yl1
|
Sh3 domain YSC-like 1 |
chr11_-_5152218 | 4.77 |
ENSMUST00000163299.1
ENSMUST00000062821.6 |
Emid1
|
EMI domain containing 1 |
chr7_+_4119525 | 4.75 |
ENSMUST00000119661.1
ENSMUST00000129423.1 |
Ttyh1
|
tweety homolog 1 (Drosophila) |
chr14_-_47189406 | 4.74 |
ENSMUST00000089959.6
|
Gch1
|
GTP cyclohydrolase 1 |
chr16_-_23890805 | 4.72 |
ENSMUST00000004480.3
|
Sst
|
somatostatin |
chr4_-_130275542 | 4.67 |
ENSMUST00000154846.1
ENSMUST00000105996.1 |
Serinc2
|
serine incorporator 2 |
chr7_-_101864093 | 4.64 |
ENSMUST00000106981.1
|
Folr1
|
folate receptor 1 (adult) |
chr6_+_47244359 | 4.60 |
ENSMUST00000060839.6
|
Cntnap2
|
contactin associated protein-like 2 |
chr2_-_38287174 | 4.57 |
ENSMUST00000130472.1
|
Dennd1a
|
DENN/MADD domain containing 1A |
chr11_+_96929260 | 4.57 |
ENSMUST00000054311.5
ENSMUST00000107636.3 |
Prr15l
|
proline rich 15-like |
chr7_-_100658364 | 4.54 |
ENSMUST00000107043.1
|
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr6_+_54326955 | 4.53 |
ENSMUST00000059138.4
|
Prr15
|
proline rich 15 |
chr7_+_121734477 | 4.45 |
ENSMUST00000000221.5
|
Scnn1g
|
sodium channel, nonvoltage-gated 1 gamma |
chr5_-_139814025 | 4.41 |
ENSMUST00000146780.1
|
Tmem184a
|
transmembrane protein 184a |
chr19_-_3686549 | 4.37 |
ENSMUST00000025856.10
ENSMUST00000176867.1 |
Lrp5
|
low density lipoprotein receptor-related protein 5 |
chr11_+_61684419 | 4.35 |
ENSMUST00000093019.5
|
Fam83g
|
family with sequence similarity 83, member G |
chr15_+_80671829 | 4.33 |
ENSMUST00000023044.5
|
Fam83f
|
family with sequence similarity 83, member F |
chr11_-_109722214 | 4.28 |
ENSMUST00000020938.7
|
Fam20a
|
family with sequence similarity 20, member A |
chr1_+_43092588 | 4.28 |
ENSMUST00000039080.3
|
8430432A02Rik
|
RIKEN cDNA 8430432A02 gene |
chr7_-_143074561 | 4.23 |
ENSMUST00000148715.1
|
Trpm5
|
transient receptor potential cation channel, subfamily M, member 5 |
chr2_-_93462386 | 4.23 |
ENSMUST00000123565.1
ENSMUST00000099696.1 |
Cd82
|
CD82 antigen |
chr4_+_106622424 | 4.22 |
ENSMUST00000047922.2
|
Ttc22
|
tetratricopeptide repeat domain 22 |
chr4_+_137277489 | 4.22 |
ENSMUST00000045747.4
|
Wnt4
|
wingless-related MMTV integration site 4 |
chr2_-_144332146 | 4.21 |
ENSMUST00000037423.3
|
Ovol2
|
ovo-like 2 (Drosophila) |
chrX_+_101383726 | 4.20 |
ENSMUST00000119190.1
|
Gjb1
|
gap junction protein, beta 1 |
chr10_-_81291227 | 4.15 |
ENSMUST00000045744.6
|
Tjp3
|
tight junction protein 3 |
chr11_+_96929367 | 4.12 |
ENSMUST00000062172.5
|
Prr15l
|
proline rich 15-like |
chr2_-_93462457 | 4.11 |
ENSMUST00000028644.4
|
Cd82
|
CD82 antigen |
chr3_+_105870898 | 4.10 |
ENSMUST00000010279.5
|
Adora3
|
adenosine A3 receptor |
chr19_-_5349574 | 4.07 |
ENSMUST00000025764.5
|
Cst6
|
cystatin E/M |
chr6_-_112489808 | 4.06 |
ENSMUST00000053306.6
|
Oxtr
|
oxytocin receptor |
chr12_-_44210061 | 4.05 |
ENSMUST00000015049.3
|
Dnajb9
|
DnaJ (Hsp40) homolog, subfamily B, member 9 |
chr17_+_23679363 | 4.04 |
ENSMUST00000024699.2
|
Cldn6
|
claudin 6 |
chr2_-_172043466 | 3.99 |
ENSMUST00000087950.3
|
Cbln4
|
cerebellin 4 precursor protein |
chr4_-_131672133 | 3.93 |
ENSMUST00000144212.1
|
Gm12962
|
predicted gene 12962 |
chr3_-_89393294 | 3.92 |
ENSMUST00000142119.1
ENSMUST00000029677.8 ENSMUST00000148361.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr17_+_47436731 | 3.92 |
ENSMUST00000150819.2
|
AI661453
|
expressed sequence AI661453 |
chr8_+_122269569 | 3.91 |
ENSMUST00000055537.2
|
Gm22
|
predicted gene 22 |
chr4_+_140906344 | 3.90 |
ENSMUST00000030765.6
|
Padi2
|
peptidyl arginine deiminase, type II |
chr5_-_139814231 | 3.89 |
ENSMUST00000044002.4
|
Tmem184a
|
transmembrane protein 184a |
chr4_-_137430517 | 3.89 |
ENSMUST00000102522.4
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr1_-_153186447 | 3.82 |
ENSMUST00000027753.6
|
Lamc2
|
laminin, gamma 2 |
chr6_+_39381175 | 3.78 |
ENSMUST00000031986.4
|
Rab19
|
RAB19, member RAS oncogene family |
chr6_-_48445678 | 3.75 |
ENSMUST00000114556.1
|
Zfp467
|
zinc finger protein 467 |
chr2_-_144331695 | 3.63 |
ENSMUST00000103171.3
|
Ovol2
|
ovo-like 2 (Drosophila) |
chr5_-_100159261 | 3.62 |
ENSMUST00000139520.1
|
Tmem150c
|
transmembrane protein 150C |
chr5_+_141241490 | 3.61 |
ENSMUST00000085774.4
|
Sdk1
|
sidekick homolog 1 (chicken) |
chr11_-_103363431 | 3.56 |
ENSMUST00000092557.5
|
Arhgap27
|
Rho GTPase activating protein 27 |
chr4_-_134238372 | 3.53 |
ENSMUST00000030645.8
|
Cnksr1
|
connector enhancer of kinase suppressor of Ras 1 |
chr12_+_108334341 | 3.53 |
ENSMUST00000021684.4
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr6_+_114131229 | 3.52 |
ENSMUST00000032451.7
|
Slc6a11
|
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
chr8_-_84147858 | 3.52 |
ENSMUST00000117424.2
ENSMUST00000040383.8 |
Cc2d1a
|
coiled-coil and C2 domain containing 1A |
chr7_+_49974864 | 3.45 |
ENSMUST00000081872.5
ENSMUST00000151721.1 |
Nell1
|
NEL-like 1 |
chrX_+_101377267 | 3.44 |
ENSMUST00000052130.7
|
Gjb1
|
gap junction protein, beta 1 |
chr2_-_129699833 | 3.44 |
ENSMUST00000028883.5
|
Pdyn
|
prodynorphin |
chr14_-_34374617 | 3.43 |
ENSMUST00000023826.4
|
Sncg
|
synuclein, gamma |
chr6_+_96115249 | 3.42 |
ENSMUST00000075080.5
|
Fam19a1
|
family with sequence similarity 19, member A1 |
chr11_-_80779989 | 3.42 |
ENSMUST00000041065.7
ENSMUST00000070997.5 |
Myo1d
|
myosin ID |
chr5_+_35757875 | 3.40 |
ENSMUST00000101280.3
ENSMUST00000054598.5 ENSMUST00000114205.1 ENSMUST00000114206.2 |
Ablim2
|
actin-binding LIM protein 2 |
chr12_-_40134175 | 3.39 |
ENSMUST00000078481.7
ENSMUST00000002640.5 |
Scin
|
scinderin |
chr4_-_137409777 | 3.39 |
ENSMUST00000024200.6
|
Gm13011
|
predicted gene 13011 |
chr16_-_18621366 | 3.33 |
ENSMUST00000051160.2
|
Gp1bb
|
glycoprotein Ib, beta polypeptide |
chr3_-_89387132 | 3.25 |
ENSMUST00000107433.1
|
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr5_+_150952607 | 3.25 |
ENSMUST00000078856.6
|
Kl
|
klotho |
chr5_+_107403496 | 3.25 |
ENSMUST00000049146.5
|
Ephx4
|
epoxide hydrolase 4 |
chr7_-_141214080 | 3.23 |
ENSMUST00000026573.5
ENSMUST00000170841.1 |
1600016N20Rik
|
RIKEN cDNA 1600016N20 gene |
chr16_-_88563166 | 3.23 |
ENSMUST00000049697.4
|
Cldn8
|
claudin 8 |
chr9_+_121760000 | 3.22 |
ENSMUST00000093772.3
|
Zfp651
|
zinc finger protein 651 |
chr7_+_128203598 | 3.21 |
ENSMUST00000177383.1
|
Itgad
|
integrin, alpha D |
chr3_+_96181151 | 3.19 |
ENSMUST00000035371.8
|
Sv2a
|
synaptic vesicle glycoprotein 2 a |
chr1_-_134235420 | 3.19 |
ENSMUST00000038191.6
ENSMUST00000086465.4 |
Adora1
|
adenosine A1 receptor |
chr15_+_9436028 | 3.19 |
ENSMUST00000042360.3
|
Capsl
|
calcyphosine-like |
chr15_+_84720052 | 3.18 |
ENSMUST00000006029.4
ENSMUST00000172307.2 |
Arhgap8
|
Rho GTPase activating protein 8 |
chr13_-_49215978 | 3.16 |
ENSMUST00000048946.6
|
1110007C09Rik
|
RIKEN cDNA 1110007C09 gene |
chr12_-_79007276 | 3.15 |
ENSMUST00000056660.6
ENSMUST00000174721.1 |
Tmem229b
|
transmembrane protein 229B |
chr4_+_43632185 | 3.11 |
ENSMUST00000107874.2
|
Npr2
|
natriuretic peptide receptor 2 |
chr13_-_62888282 | 3.09 |
ENSMUST00000092888.4
|
Fbp1
|
fructose bisphosphatase 1 |
chr3_+_107101551 | 3.08 |
ENSMUST00000038695.1
|
Kcna2
|
potassium voltage-gated channel, shaker-related subfamily, member 2 |
chr2_-_38287347 | 3.08 |
ENSMUST00000102787.3
|
Dennd1a
|
DENN/MADD domain containing 1A |
chr5_-_52471534 | 3.07 |
ENSMUST00000059428.5
|
Ccdc149
|
coiled-coil domain containing 149 |
chr7_-_138846202 | 3.06 |
ENSMUST00000118810.1
ENSMUST00000075667.4 ENSMUST00000119664.1 |
Mapk1ip1
|
mitogen-activated protein kinase 1 interacting protein 1 |
chr4_+_118526986 | 3.04 |
ENSMUST00000106367.1
|
2610528J11Rik
|
RIKEN cDNA 2610528J11 gene |
chr13_-_13393592 | 3.03 |
ENSMUST00000021738.8
|
Gpr137b
|
G protein-coupled receptor 137B |
chr2_+_164562579 | 3.03 |
ENSMUST00000017867.3
ENSMUST00000109344.2 ENSMUST00000109345.2 |
Wfdc2
|
WAP four-disulfide core domain 2 |
chr13_-_58610877 | 3.02 |
ENSMUST00000022036.7
|
Slc28a3
|
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
chr9_+_59589288 | 3.02 |
ENSMUST00000121266.1
ENSMUST00000118164.1 |
Celf6
|
CUGBP, Elav-like family member 6 |
chr4_-_58553553 | 3.01 |
ENSMUST00000107575.2
ENSMUST00000107574.1 ENSMUST00000147354.1 |
Lpar1
|
lysophosphatidic acid receptor 1 |
chr11_+_9118507 | 3.00 |
ENSMUST00000164791.1
ENSMUST00000130522.1 |
Upp1
|
uridine phosphorylase 1 |
chr14_-_70635946 | 2.99 |
ENSMUST00000022695.9
|
Dmtn
|
dematin actin binding protein |
chr11_+_16752203 | 2.98 |
ENSMUST00000102884.3
ENSMUST00000020329.6 |
Egfr
|
epidermal growth factor receptor |
chrX_+_159627265 | 2.97 |
ENSMUST00000112456.2
|
Sh3kbp1
|
SH3-domain kinase binding protein 1 |
chr2_-_121807024 | 2.97 |
ENSMUST00000138157.1
|
Frmd5
|
FERM domain containing 5 |
chr4_+_133518963 | 2.96 |
ENSMUST00000149807.1
ENSMUST00000042919.9 ENSMUST00000153811.1 ENSMUST00000105901.1 ENSMUST00000121797.1 |
1810019J16Rik
|
RIKEN cDNA 1810019J16 gene |
chr2_+_92915080 | 2.96 |
ENSMUST00000028648.2
|
Syt13
|
synaptotagmin XIII |
chr2_+_25395866 | 2.96 |
ENSMUST00000028328.2
|
Entpd2
|
ectonucleoside triphosphate diphosphohydrolase 2 |
chr17_+_47436615 | 2.94 |
ENSMUST00000037701.6
|
AI661453
|
expressed sequence AI661453 |
chr11_+_114851814 | 2.94 |
ENSMUST00000053361.5
ENSMUST00000021071.7 ENSMUST00000136785.1 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr6_-_124738714 | 2.94 |
ENSMUST00000171549.2
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr7_-_66427469 | 2.93 |
ENSMUST00000015278.7
|
Aldh1a3
|
aldehyde dehydrogenase family 1, subfamily A3 |
chr3_-_89393629 | 2.92 |
ENSMUST00000124783.1
ENSMUST00000126027.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr8_-_105933832 | 2.91 |
ENSMUST00000034368.6
|
Ctrl
|
chymotrypsin-like |
chr8_+_76902277 | 2.89 |
ENSMUST00000109912.1
ENSMUST00000128862.1 ENSMUST00000109911.1 |
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr3_+_89229046 | 2.89 |
ENSMUST00000041142.3
|
Muc1
|
mucin 1, transmembrane |
chr6_-_48445825 | 2.88 |
ENSMUST00000114561.2
|
Zfp467
|
zinc finger protein 467 |
chr4_+_133480126 | 2.87 |
ENSMUST00000051676.6
|
Fam46b
|
family with sequence similarity 46, member B |
chr6_-_87690819 | 2.87 |
ENSMUST00000162547.1
|
1810020O05Rik
|
Riken cDNA 1810020O05 gene |
chr4_-_148500449 | 2.86 |
ENSMUST00000030840.3
|
Angptl7
|
angiopoietin-like 7 |
chr8_-_70487314 | 2.85 |
ENSMUST00000045286.7
|
Tmem59l
|
transmembrane protein 59-like |
chr11_+_93099284 | 2.85 |
ENSMUST00000092780.3
ENSMUST00000107863.2 |
Car10
|
carbonic anhydrase 10 |
chr15_-_55906917 | 2.84 |
ENSMUST00000039769.5
|
Sntb1
|
syntrophin, basic 1 |
chr19_+_52264323 | 2.83 |
ENSMUST00000039652.4
|
Ins1
|
insulin I |
chr7_-_4546567 | 2.81 |
ENSMUST00000065957.5
|
Syt5
|
synaptotagmin V |
chr4_-_130275213 | 2.80 |
ENSMUST00000122374.1
|
Serinc2
|
serine incorporator 2 |
chr11_-_115367667 | 2.80 |
ENSMUST00000123428.1
ENSMUST00000044152.6 ENSMUST00000106542.2 |
Hid1
|
HID1 domain containing |
chr17_+_36943025 | 2.79 |
ENSMUST00000173072.1
|
Rnf39
|
ring finger protein 39 |
chr1_-_124045523 | 2.79 |
ENSMUST00000112606.1
|
Dpp10
|
dipeptidylpeptidase 10 |
chr7_-_30856178 | 2.78 |
ENSMUST00000094583.1
|
Ffar3
|
free fatty acid receptor 3 |
chr7_-_128206346 | 2.77 |
ENSMUST00000033049.7
|
Cox6a2
|
cytochrome c oxidase subunit VIa polypeptide 2 |
chr15_+_76660564 | 2.76 |
ENSMUST00000004294.10
|
Kifc2
|
kinesin family member C2 |
chr14_+_41105359 | 2.76 |
ENSMUST00000047286.6
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr3_-_88369730 | 2.75 |
ENSMUST00000075523.4
|
Bglap3
|
bone gamma-carboxyglutamate protein 3 |
chr2_-_121806988 | 2.71 |
ENSMUST00000110592.1
|
Frmd5
|
FERM domain containing 5 |
chr4_-_156059414 | 2.70 |
ENSMUST00000184348.1
|
Ttll10
|
tubulin tyrosine ligase-like family, member 10 |
chr17_-_6827990 | 2.70 |
ENSMUST00000181895.1
|
Gm2885
|
predicted gene 2885 |
chr18_+_24653691 | 2.69 |
ENSMUST00000068006.7
|
Mocos
|
molybdenum cofactor sulfurase |
chr3_+_106482427 | 2.69 |
ENSMUST00000029508.4
|
Dennd2d
|
DENN/MADD domain containing 2D |
chr2_-_5063996 | 2.68 |
ENSMUST00000114996.1
|
Optn
|
optineurin |
chr9_-_57836706 | 2.68 |
ENSMUST00000164010.1
ENSMUST00000171444.1 ENSMUST00000098686.3 |
Arid3b
|
AT rich interactive domain 3B (BRIGHT-like) |
chr7_-_27553138 | 2.67 |
ENSMUST00000127240.1
ENSMUST00000117095.1 ENSMUST00000117611.1 |
Pld3
|
phospholipase D family, member 3 |
chr2_+_31887262 | 2.67 |
ENSMUST00000138325.1
ENSMUST00000028187.6 |
Lamc3
|
laminin gamma 3 |
chr2_+_168081004 | 2.67 |
ENSMUST00000052125.6
|
Pard6b
|
par-6 (partitioning defective 6) homolog beta (C. elegans) |
chr4_-_154026037 | 2.66 |
ENSMUST00000131325.2
ENSMUST00000146054.1 ENSMUST00000126119.1 ENSMUST00000125533.2 |
Smim1
|
small integral membrane protein 1 |
chr11_-_72135721 | 2.65 |
ENSMUST00000108508.2
ENSMUST00000075258.6 |
Pitpnm3
|
PITPNM family member 3 |
chr7_-_30445508 | 2.65 |
ENSMUST00000006828.7
|
Aplp1
|
amyloid beta (A4) precursor-like protein 1 |
chr4_-_130275523 | 2.64 |
ENSMUST00000146478.1
|
Serinc2
|
serine incorporator 2 |
chr17_-_24689901 | 2.64 |
ENSMUST00000007236.4
|
Syngr3
|
synaptogyrin 3 |
chr4_+_120666562 | 2.62 |
ENSMUST00000094814.4
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr4_-_118544010 | 2.62 |
ENSMUST00000128098.1
|
Tmem125
|
transmembrane protein 125 |
chr12_-_87102522 | 2.61 |
ENSMUST00000110177.2
ENSMUST00000021420.7 |
Ngb
|
neuroglobin |
chr2_-_155729359 | 2.61 |
ENSMUST00000040833.4
|
Edem2
|
ER degradation enhancer, mannosidase alpha-like 2 |
chr16_-_97611072 | 2.61 |
ENSMUST00000000395.6
|
Tmprss2
|
transmembrane protease, serine 2 |
chr15_+_34453285 | 2.60 |
ENSMUST00000060894.7
|
BC030476
|
cDNA sequence BC030476 |
chr16_+_20696175 | 2.59 |
ENSMUST00000128273.1
|
Fam131a
|
family with sequence similarity 131, member A |
chr6_+_39420378 | 2.58 |
ENSMUST00000090237.2
|
Gm10244
|
predicted gene 10244 |
chr4_-_152038568 | 2.58 |
ENSMUST00000030792.1
|
Tas1r1
|
taste receptor, type 1, member 1 |
chr2_-_62483637 | 2.57 |
ENSMUST00000136686.1
ENSMUST00000102733.3 |
Gcg
|
glucagon |
chr6_-_137169710 | 2.57 |
ENSMUST00000117919.1
|
Rerg
|
RAS-like, estrogen-regulated, growth-inhibitor |
chr10_+_115817247 | 2.56 |
ENSMUST00000035563.7
ENSMUST00000080630.3 ENSMUST00000179196.1 |
Tspan8
|
tetraspanin 8 |
chr17_+_26933070 | 2.56 |
ENSMUST00000073724.5
|
Phf1
|
PHD finger protein 1 |
chr1_+_131599239 | 2.55 |
ENSMUST00000027690.6
|
Avpr1b
|
arginine vasopressin receptor 1B |
chr8_+_76899772 | 2.54 |
ENSMUST00000109913.2
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr2_-_114013619 | 2.54 |
ENSMUST00000090275.4
|
Gjd2
|
gap junction protein, delta 2 |
chr7_+_143473736 | 2.52 |
ENSMUST00000052348.5
|
Slc22a18
|
solute carrier family 22 (organic cation transporter), member 18 |
chr2_+_119237453 | 2.52 |
ENSMUST00000110816.1
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr18_-_60624201 | 2.52 |
ENSMUST00000155195.2
|
Synpo
|
synaptopodin |
chr7_+_141078188 | 2.50 |
ENSMUST00000106039.2
|
Pkp3
|
plakophilin 3 |
chr3_+_27371351 | 2.50 |
ENSMUST00000057186.1
|
Ghsr
|
growth hormone secretagogue receptor |
chr2_+_164403194 | 2.49 |
ENSMUST00000017151.1
|
Rbpjl
|
recombination signal binding protein for immunoglobulin kappa J region-like |
chr4_+_43631935 | 2.49 |
ENSMUST00000030191.8
|
Npr2
|
natriuretic peptide receptor 2 |
chr2_+_119351222 | 2.49 |
ENSMUST00000028780.3
|
Chac1
|
ChaC, cation transport regulator 1 |
chr7_-_140082246 | 2.49 |
ENSMUST00000166758.2
|
Caly
|
calcyon neuron-specific vesicular protein |
chr7_-_31054815 | 2.48 |
ENSMUST00000071697.4
ENSMUST00000108110.3 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 12.0 | GO:0032242 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) |
2.7 | 16.5 | GO:0032439 | endosome localization(GO:0032439) |
2.5 | 10.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
2.3 | 43.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
2.3 | 4.5 | GO:0072034 | renal vesicle induction(GO:0072034) |
1.9 | 5.7 | GO:0042197 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
1.8 | 5.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
1.8 | 5.4 | GO:1904349 | positive regulation of small intestine smooth muscle contraction(GO:1904349) |
1.8 | 10.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.6 | 7.8 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.5 | 10.8 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.5 | 6.0 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
1.5 | 5.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
1.5 | 4.4 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
1.5 | 4.4 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.4 | 4.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
1.4 | 16.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.4 | 5.6 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
1.3 | 5.3 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.3 | 6.5 | GO:0098886 | modification of dendritic spine(GO:0098886) |
1.3 | 6.5 | GO:0033762 | response to glucagon(GO:0033762) |
1.3 | 5.2 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
1.2 | 7.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.2 | 9.8 | GO:0060214 | endocardium formation(GO:0060214) |
1.2 | 2.4 | GO:0051464 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
1.2 | 6.0 | GO:0070384 | Harderian gland development(GO:0070384) |
1.2 | 7.2 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
1.2 | 3.5 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
1.1 | 3.4 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
1.1 | 3.4 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
1.1 | 12.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.1 | 3.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.1 | 2.1 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.0 | 5.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.0 | 1.0 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
1.0 | 3.0 | GO:0009095 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
1.0 | 3.0 | GO:1902728 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
1.0 | 3.0 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
1.0 | 3.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.0 | 3.9 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
1.0 | 4.8 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.0 | 3.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.0 | 5.7 | GO:0002159 | desmosome assembly(GO:0002159) |
1.0 | 2.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.0 | 2.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.0 | 4.8 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.9 | 15.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.9 | 1.9 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.9 | 5.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.9 | 8.0 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.9 | 4.4 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.9 | 3.5 | GO:0030070 | insulin processing(GO:0030070) |
0.9 | 2.6 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.9 | 4.3 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.8 | 2.5 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.8 | 2.5 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.8 | 8.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.8 | 1.6 | GO:0035483 | gastric emptying(GO:0035483) |
0.8 | 2.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.8 | 3.2 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.8 | 2.4 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.8 | 2.4 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.8 | 3.9 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.8 | 2.3 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.8 | 3.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.8 | 2.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.8 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.7 | 4.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.7 | 3.7 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.7 | 2.2 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.7 | 2.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.7 | 6.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.7 | 2.1 | GO:1905034 | regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.7 | 2.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.7 | 2.8 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.7 | 2.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.7 | 2.8 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.7 | 1.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.7 | 7.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.7 | 2.0 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.7 | 1.4 | GO:2000331 | regulation of terminal button organization(GO:2000331) |
0.7 | 5.4 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.7 | 0.7 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.7 | 2.0 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.7 | 2.7 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.7 | 3.3 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.6 | 1.9 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.6 | 0.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.6 | 4.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.6 | 3.2 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
0.6 | 2.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 2.5 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.6 | 0.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.6 | 2.5 | GO:0033869 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.6 | 0.6 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.6 | 1.8 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.6 | 3.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.6 | 6.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.6 | 3.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 0.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.6 | 4.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.6 | 0.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.6 | 1.8 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.6 | 0.6 | GO:2000722 | regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.6 | 4.1 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.6 | 1.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.6 | 3.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 1.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.6 | 6.2 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 2.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.6 | 1.7 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.6 | 3.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.5 | 7.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.5 | 1.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 1.6 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.5 | 4.8 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.5 | 2.1 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.5 | 2.1 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.5 | 1.1 | GO:0098923 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) |
0.5 | 2.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.5 | 3.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.5 | 3.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.5 | 1.0 | GO:1990401 | embryonic lung development(GO:1990401) |
0.5 | 4.6 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.5 | 1.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 0.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.5 | 3.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.5 | 1.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.5 | 3.0 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.5 | 1.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.5 | 2.0 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.5 | 2.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.5 | 1.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.5 | 2.5 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.5 | 3.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.5 | 4.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 3.4 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
0.5 | 1.9 | GO:0060003 | copper ion export(GO:0060003) |
0.5 | 4.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.5 | 1.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.5 | 2.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 2.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 16.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.5 | 2.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 1.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.5 | 1.4 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.5 | 0.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 1.4 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.5 | 3.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.5 | 3.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.5 | 5.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.5 | 2.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.5 | 0.5 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.4 | 0.4 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.4 | 1.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 4.0 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 1.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.4 | 2.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.4 | 1.3 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.4 | 2.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.4 | 2.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.4 | 1.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 2.2 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 0.9 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.4 | 2.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 0.9 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 2.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 1.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.4 | 1.3 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.4 | 1.3 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.4 | 1.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 3.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.4 | 0.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 4.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.4 | 2.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.4 | 2.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 2.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 2.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 2.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 3.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 0.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.4 | 0.8 | GO:0034757 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.4 | 2.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.4 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.4 | 1.2 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.4 | 0.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.4 | 2.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.4 | 3.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 1.6 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.4 | 0.8 | GO:0035482 | gastric motility(GO:0035482) |
0.4 | 3.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 2.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 0.8 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.4 | 3.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.4 | 1.2 | GO:0030862 | neuroblast division in subventricular zone(GO:0021849) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.4 | 1.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 6.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 1.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 0.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 1.5 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.4 | 2.3 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 2.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 0.7 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.4 | 1.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 3.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 1.1 | GO:0009726 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.4 | 3.7 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.4 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 1.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
0.4 | 1.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.4 | 2.2 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.4 | 1.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.4 | 1.1 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.4 | 2.9 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.4 | 0.4 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.4 | 0.7 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.4 | 0.4 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.4 | 1.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.4 | 0.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.4 | 1.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.3 | 0.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.3 | 1.4 | GO:0035106 | operant conditioning(GO:0035106) |
0.3 | 0.7 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.3 | 1.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 1.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 1.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 0.7 | GO:0060032 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
0.3 | 1.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 10.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.3 | 0.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 3.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.3 | 1.3 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.3 | 2.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 3.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.3 | 1.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 12.4 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.3 | 1.9 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 2.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.3 | 1.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 4.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 1.3 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 3.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.3 | 2.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 2.2 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.3 | 5.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 0.9 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.3 | 0.9 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 1.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 1.2 | GO:0060376 | positive regulation of mast cell differentiation(GO:0060376) |
0.3 | 1.5 | GO:0051610 | serotonin uptake(GO:0051610) |
0.3 | 0.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.9 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.3 | 2.4 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.3 | 1.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 1.2 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.3 | 1.2 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.3 | 0.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.3 | 1.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 1.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 | 1.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 0.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 2.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.3 | 2.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.3 | 0.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.3 | 2.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 0.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 2.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 0.9 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.3 | 1.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 0.9 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.3 | 2.3 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.3 | 0.6 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
0.3 | 1.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 1.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.3 | 2.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 0.8 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.3 | 0.6 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.3 | 11.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.3 | 1.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 2.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 0.8 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.3 | 1.1 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
0.3 | 1.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 1.9 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.3 | 1.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 1.3 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.3 | 0.3 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.3 | 0.5 | GO:0046959 | habituation(GO:0046959) |
0.3 | 1.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.3 | 1.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.8 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.3 | 2.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 2.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 12.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 3.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 1.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.3 | 0.8 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.3 | 0.5 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.3 | 1.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.3 | 2.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 2.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.3 | 0.8 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.3 | 1.8 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.3 | 0.8 | GO:0021558 | trochlear nerve development(GO:0021558) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.3 | 1.0 | GO:0033575 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.3 | 1.0 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.3 | 1.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 2.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.5 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 0.8 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.3 | 1.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 1.5 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 4.5 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.2 | 1.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 1.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.2 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.2 | 3.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.2 | 0.5 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
0.2 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.7 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.7 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 1.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.2 | GO:0071655 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.2 | 1.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 0.2 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.2 | 1.9 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 0.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 3.5 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.2 | 0.9 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 1.2 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 1.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 1.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 1.6 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 2.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.5 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.2 | 2.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.5 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 2.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 1.3 | GO:0098961 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.2 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 1.3 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.2 | 0.9 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 4.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.9 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.2 | 3.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.2 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.2 | 0.2 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.2 | 2.2 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.2 | 0.7 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 2.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 2.4 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 2.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.2 | 1.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 1.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.6 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 0.4 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.2 | 0.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.2 | 1.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.4 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.2 | 3.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 0.9 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 1.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.2 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.2 | 7.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 0.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 1.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 0.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 4.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 6.9 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 2.1 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 1.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.2 | 0.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 1.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.6 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.2 | 1.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.2 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.2 | 3.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.2 | 3.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 6.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 10.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 1.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 1.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 0.4 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 0.2 | GO:0060592 | mammary gland formation(GO:0060592) |
0.2 | 0.6 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.8 | GO:0048880 | sensory system development(GO:0048880) |
0.2 | 0.4 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.2 | 1.0 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.2 | 0.4 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.2 | 1.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 1.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 1.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.8 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.2 | 0.6 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.2 | 0.6 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.2 | 1.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 2.5 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 1.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.2 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.2 | 1.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.2 | 0.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.4 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.2 | 0.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 1.7 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.2 | 0.7 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.2 | 0.6 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 1.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 2.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.3 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.2 | 1.3 | GO:0003283 | atrial septum development(GO:0003283) |
0.2 | 1.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 1.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 3.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 2.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 0.5 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 2.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.2 | 0.9 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.2 | 1.3 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.5 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.5 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 3.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.7 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 0.4 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.2 | 2.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 2.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 2.1 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.4 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.2 | 0.4 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.5 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 2.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.9 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.2 | 0.4 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 8.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 1.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 1.4 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 1.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.3 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 2.6 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 0.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 1.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 1.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 1.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.5 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.2 | 0.7 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 1.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.2 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.2 | 2.5 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.7 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.2 | 7.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 1.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 1.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.3 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.2 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.8 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.2 | 0.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 1.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 2.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 1.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 4.3 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.2 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.5 | GO:0019085 | early viral transcription(GO:0019085) |
0.2 | 0.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.0 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.2 | 1.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 1.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.6 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 0.2 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 1.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.5 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.2 | 3.9 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.2 | 1.7 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 0.5 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 2.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 0.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 2.2 | GO:0099612 | protein localization to axon(GO:0099612) |
0.2 | 3.2 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 0.6 | GO:0032218 | riboflavin transport(GO:0032218) |
0.2 | 0.5 | GO:0002353 | plasma kallikrein-kinin cascade(GO:0002353) |
0.2 | 0.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 2.6 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 2.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.2 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.4 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.1 | 5.7 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.1 | 0.4 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.1 | 0.7 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.4 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 0.3 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of progesterone secretion(GO:2000872) |
0.1 | 1.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.4 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.1 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) |
0.1 | 2.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.6 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 1.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.6 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.1 | 2.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.4 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.1 | 2.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.1 | GO:0071724 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.1 | 0.7 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.1 | 1.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.4 | GO:2000698 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.1 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 1.8 | GO:0007567 | parturition(GO:0007567) |
0.1 | 1.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 1.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 2.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 2.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.5 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 2.3 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 1.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 1.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.5 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.1 | 0.4 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.1 | 1.2 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.8 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.8 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 3.3 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
0.1 | 1.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 1.9 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.5 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 1.1 | GO:0070723 | response to cholesterol(GO:0070723) |
0.1 | 1.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 1.9 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 2.0 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 1.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 1.5 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.1 | 0.1 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.1 | 0.4 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 1.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 1.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 1.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.4 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.1 | 0.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.4 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 8.0 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.1 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.2 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.1 | 0.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 2.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 1.6 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 1.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 2.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 0.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.3 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.3 | GO:1990743 | protein sialylation(GO:1990743) |
0.1 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 1.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 1.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 1.5 | GO:0010043 | response to zinc ion(GO:0010043) |
0.1 | 0.6 | GO:0060180 | female mating behavior(GO:0060180) |
0.1 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.6 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 1.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 1.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.2 | GO:0035385 | axon midline choice point recognition(GO:0016199) Roundabout signaling pathway(GO:0035385) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.5 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 0.3 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) intestine smooth muscle contraction(GO:0014827) |
0.1 | 1.0 | GO:1902592 | viral budding via host ESCRT complex(GO:0039702) viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 0.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.6 | GO:1901910 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 1.6 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 1.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.3 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.1 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.2 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.1 | 0.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 1.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.3 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.1 | 0.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 0.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.4 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.7 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 1.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.8 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 2.5 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.1 | 0.1 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.9 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.7 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.1 | 0.5 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.4 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.4 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 4.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 3.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.8 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.5 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.4 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.1 | 1.1 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.2 | GO:0031620 | regulation of fever generation(GO:0031620) |
0.1 | 0.5 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 0.7 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.2 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.1 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 3.1 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 2.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.3 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 1.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.8 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 1.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.1 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.1 | 0.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.4 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.3 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 4.1 | GO:0002793 | positive regulation of peptide secretion(GO:0002793) |
0.1 | 0.3 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.1 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.1 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 1.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 2.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.4 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 1.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.3 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.2 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.1 | 0.3 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.1 | 1.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.9 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.3 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.1 | 0.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 3.1 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.2 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 1.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.8 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 0.4 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.3 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.9 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0010886 | regulation of cholesterol storage(GO:0010885) positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.7 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 1.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.3 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.9 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.1 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
0.1 | 0.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.2 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.8 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 2.4 | GO:0071514 | genetic imprinting(GO:0071514) |
0.1 | 0.1 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.1 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.9 | GO:0048265 | response to pain(GO:0048265) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.3 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 0.2 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 0.6 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.6 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.3 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.3 | GO:0030473 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.1 | 0.5 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 1.5 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 0.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.6 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.1 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.7 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0035812 | renal sodium excretion(GO:0035812) |
0.0 | 0.2 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 1.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.4 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.0 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.5 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.4 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.0 | 0.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 1.3 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 1.1 | GO:0003281 | ventricular septum development(GO:0003281) |
0.0 | 0.9 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.0 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 0.3 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.0 | 0.1 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.0 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.5 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.0 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.0 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.2 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.2 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.4 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.3 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.3 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.6 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.6 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.3 | GO:0042454 | purine nucleoside catabolic process(GO:0006152) ribonucleoside catabolic process(GO:0042454) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.6 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.3 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.0 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.3 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 1.0 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.3 | GO:0042711 | maternal behavior(GO:0042711) |
0.0 | 0.4 | GO:0003170 | heart valve development(GO:0003170) |
0.0 | 0.6 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.0 | 0.4 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.4 | GO:0042311 | vasodilation(GO:0042311) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.2 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.0 | 0.4 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.4 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.0 | 0.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.6 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.0 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.4 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.0 | 0.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.0 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 1.7 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.2 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.0 | 0.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.0 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.2 | GO:1901070 | GTP biosynthetic process(GO:0006183) guanosine-containing compound biosynthetic process(GO:1901070) |
0.0 | 0.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.6 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.1 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.6 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.0 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 1.1 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.0 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.0 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) medium-chain fatty acid biosynthetic process(GO:0051792) |
0.0 | 0.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.2 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.7 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) |
0.0 | 0.1 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.0 | GO:0021940 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.0 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.0 | 0.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.2 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.0 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 0.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.0 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 10.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.1 | 8.4 | GO:0005914 | spot adherens junction(GO:0005914) |
1.7 | 43.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.7 | 1.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.4 | 5.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.1 | 15.6 | GO:0045179 | apical cortex(GO:0045179) |
1.1 | 5.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.0 | 2.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.9 | 10.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.8 | 3.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.8 | 3.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.8 | 5.8 | GO:0097444 | spine apparatus(GO:0097444) |
0.8 | 3.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.7 | 14.7 | GO:0005922 | connexon complex(GO:0005922) |
0.7 | 2.1 | GO:0060205 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.7 | 6.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 2.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.6 | 3.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.6 | 1.9 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.6 | 0.6 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.6 | 4.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.6 | 4.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.6 | 0.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 2.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.6 | 1.7 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.5 | 2.1 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.5 | 1.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.5 | 11.9 | GO:0033268 | node of Ranvier(GO:0033268) |
0.5 | 19.3 | GO:0030673 | axolemma(GO:0030673) |
0.5 | 2.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 12.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 6.2 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 1.9 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.4 | 1.3 | GO:0005713 | recombination nodule(GO:0005713) |
0.4 | 1.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 3.9 | GO:0097227 | sperm annulus(GO:0097227) |
0.4 | 7.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 1.7 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 2.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 3.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.4 | 6.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 1.2 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.4 | 3.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 10.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 3.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 1.5 | GO:0097447 | dendritic tree(GO:0097447) |
0.4 | 1.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 2.6 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 2.2 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.4 | 8.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 1.8 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.4 | 4.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 0.4 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.4 | 2.5 | GO:0031105 | septin complex(GO:0031105) |
0.4 | 1.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 1.1 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.3 | 2.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 2.0 | GO:0044305 | calyx of Held(GO:0044305) |
0.3 | 3.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 7.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 6.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 2.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 0.9 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 0.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 2.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 1.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.3 | 0.8 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 0.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 11.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 1.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 2.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 4.4 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 7.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.9 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.2 | 0.7 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 3.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 1.2 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 3.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 3.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 0.7 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.2 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 5.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 4.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 0.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.2 | 1.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.4 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 1.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.8 | GO:0032437 | muscle tendon junction(GO:0005927) cuticular plate(GO:0032437) |
0.2 | 1.5 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.2 | 1.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 7.2 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 1.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 1.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 10.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 1.8 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.9 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.6 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 1.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.5 | GO:0098855 | HCN channel complex(GO:0098855) |
0.2 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 1.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.7 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 2.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 1.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 5.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 3.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 2.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 0.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 3.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 2.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 1.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 2.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 2.0 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.1 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.6 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 0.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 1.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.8 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.6 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.1 | 1.1 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.4 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 0.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 3.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 8.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 2.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.9 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 3.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 1.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.8 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 14.2 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 0.9 | GO:0002177 | manchette(GO:0002177) |
0.1 | 22.3 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.7 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 2.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.6 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 3.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 1.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.8 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.7 | GO:0031430 | M band(GO:0031430) |
0.1 | 9.8 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 3.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 1.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.5 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 2.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 2.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 3.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.9 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 1.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 1.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 1.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 6.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.3 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 3.1 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 1.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.1 | 62.1 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.9 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.2 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.1 | 9.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.2 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.1 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 61.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 2.1 | GO:0012506 | vesicle membrane(GO:0012506) |
0.0 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 4.1 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.6 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.0 | 117.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 1.0 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 2.0 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.6 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 2.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.8 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.9 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 1.0 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 1.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.0 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
2.5 | 10.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
2.2 | 8.6 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
2.0 | 10.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.0 | 6.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
1.9 | 5.7 | GO:0016824 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
1.6 | 18.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.5 | 4.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.4 | 4.3 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.4 | 4.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.4 | 4.2 | GO:0005118 | sevenless binding(GO:0005118) |
1.3 | 3.9 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
1.3 | 5.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
1.3 | 8.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.1 | 3.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
1.1 | 8.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.0 | 3.1 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
1.0 | 3.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
1.0 | 5.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.9 | 2.8 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.9 | 2.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.9 | 7.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.9 | 3.6 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.9 | 2.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.9 | 3.5 | GO:0070976 | TIR domain binding(GO:0070976) |
0.9 | 13.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.8 | 3.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.8 | 5.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.8 | 11.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.8 | 8.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.8 | 3.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.8 | 2.3 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.7 | 3.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.7 | 10.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 4.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.7 | 2.1 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.7 | 2.1 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.7 | 2.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.7 | 4.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 1.4 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.7 | 2.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.7 | 2.1 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.7 | 3.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.6 | 2.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.6 | 1.9 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.6 | 1.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.6 | 1.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.6 | 4.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 5.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 2.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.6 | 4.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 1.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.6 | 2.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.6 | 2.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.6 | 3.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.6 | 4.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.6 | 3.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.6 | 1.8 | GO:0046911 | metal chelating activity(GO:0046911) |
0.6 | 1.8 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.6 | 2.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.6 | 1.7 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.6 | 2.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.6 | 4.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 3.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.5 | 0.5 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.5 | 3.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 2.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.5 | 8.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 1.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.5 | 1.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 1.6 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.5 | 2.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.5 | 1.5 | GO:0070401 | NADP+ binding(GO:0070401) |
0.5 | 5.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.5 | 0.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.5 | 3.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 4.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.5 | 1.5 | GO:2001069 | glycogen binding(GO:2001069) |
0.5 | 2.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.5 | 2.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 2.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.5 | 2.9 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.5 | 4.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 1.9 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.5 | 6.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 17.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.5 | 1.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 1.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 4.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 3.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 6.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 0.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 4.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 1.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 5.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 2.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 4.6 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 0.8 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.4 | 2.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 1.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.4 | 2.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 4.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.9 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.4 | 1.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.4 | 1.9 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 5.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 1.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 2.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 6.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 2.8 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 3.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 0.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.3 | 4.8 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 18.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 2.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 1.0 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.3 | 0.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 0.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 1.3 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.3 | 1.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 2.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 2.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.3 | 1.6 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.3 | 1.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 2.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 2.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 15.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 2.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 1.6 | GO:0032810 | sterol response element binding(GO:0032810) |
0.3 | 1.3 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.3 | 3.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 0.9 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 2.5 | GO:0016160 | amylase activity(GO:0016160) |
0.3 | 0.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.3 | 1.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 1.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 2.4 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.3 | 1.2 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.3 | 1.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 2.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 1.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 1.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 1.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 9.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 1.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.3 | 5.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 6.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 2.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 4.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 1.1 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) maltose alpha-glucosidase activity(GO:0032450) |
0.3 | 0.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 1.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.3 | 0.8 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
0.3 | 1.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 3.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.3 | 1.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 0.8 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.3 | 4.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 2.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 3.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 1.8 | GO:0015923 | mannosidase activity(GO:0015923) |
0.3 | 2.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.3 | 1.8 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.3 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 1.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 0.5 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.3 | 1.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 1.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.2 | 1.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 1.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.5 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.2 | 1.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 12.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 6.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 3.6 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.5 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 1.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 3.3 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.2 | 5.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 2.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 1.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 1.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.2 | 1.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 2.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 2.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 1.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 1.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 13.8 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 0.6 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.2 | 2.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 1.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.8 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 0.4 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.2 | 0.6 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.2 | 2.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 1.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.6 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.6 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 2.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 6.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 3.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 2.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 2.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 0.6 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.2 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.6 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.2 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 7.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.9 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.2 | 3.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 4.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 2.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 1.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 5.0 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.2 | 4.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 3.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.7 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.2 | 5.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.7 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 1.4 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 0.5 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.2 | 1.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 1.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.2 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 1.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.7 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 1.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.8 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 1.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 0.8 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 2.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 1.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.5 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 7.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 4.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 2.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 1.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.6 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.2 | 2.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 3.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 2.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.4 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 1.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 1.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 1.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.3 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.1 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 2.0 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 24.1 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.4 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 1.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.5 | GO:2001070 | glycerophosphocholine phosphodiesterase activity(GO:0047389) starch binding(GO:2001070) |
0.1 | 1.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 2.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 2.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.1 | 0.5 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.1 | 0.4 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 0.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 9.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.4 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.9 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 2.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 2.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 1.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 1.0 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 11.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 1.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0016635 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 2.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.6 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.1 | 0.2 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 1.4 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 6.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.4 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.1 | 2.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.1 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.4 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 0.3 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 1.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 1.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 2.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 1.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 1.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.6 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 0.7 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.9 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 5.5 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.2 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.1 | 0.3 | GO:0005302 | hydrogen:amino acid symporter activity(GO:0005280) L-tyrosine transmembrane transporter activity(GO:0005302) |
0.1 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 3.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 1.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 2.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.1 | 10.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 2.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 11.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 4.3 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 2.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.1 | 3.8 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.2 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.1 | 2.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 2.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 2.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 1.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 1.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 1.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.4 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.9 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 3.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.0 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.1 | 0.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 2.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.4 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.2 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.1 | 0.1 | GO:1902121 | lithocholic acid binding(GO:1902121) |
0.1 | 0.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.9 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 1.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.2 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 0.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 1.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.2 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.2 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.1 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 29.2 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 1.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 2.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.2 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.1 | 0.2 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.1 | 0.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 1.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 3.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.0 | 1.4 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 1.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 2.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.2 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.1 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.3 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 2.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.0 | 1.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.3 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.2 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 3.8 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.3 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 1.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 1.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.9 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.0 | 0.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 3.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 1.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 10.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 1.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 1.7 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.0 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 4.7 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.0 | 0.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 2.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 11.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 2.9 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 8.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 4.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 2.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 10.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 4.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 7.0 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 4.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 5.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 2.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 5.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 4.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 40.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 1.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 6.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 6.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 1.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 4.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 6.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 4.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 3.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 4.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 6.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 2.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 4.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 8.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 6.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 6.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 4.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 3.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 14.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 3.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 14.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 4.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 6.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
1.8 | 73.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.0 | 18.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.9 | 14.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.6 | 9.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.5 | 3.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 7.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 4.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 3.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 9.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 3.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 8.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 2.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 1.2 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.3 | 0.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 3.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 0.6 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.3 | 4.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 4.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 3.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 1.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 2.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 5.0 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 7.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 3.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 2.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 2.0 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.2 | 2.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 1.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 3.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 29.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 2.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 3.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 7.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 1.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 2.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 1.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 9.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 2.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 2.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 2.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 3.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 13.5 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.2 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 0.2 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.2 | 2.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 2.1 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 1.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 5.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.9 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 1.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 7.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 4.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 3.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 4.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 2.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 2.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 4.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 1.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 4.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 6.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 5.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 6.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 3.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 1.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 4.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 2.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 3.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 2.2 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.1 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.6 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.9 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 1.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.5 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 1.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.0 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 1.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 1.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 2.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 1.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.0 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |